Stock Updates

Bristol-Myers Squibb Company (NYSE: BMY) – Is this large market cap stock undervalued?

Bristol-Myers Squibb Company (NYSE: BMY), is firmly in the large market cap category with market cap of 93518.09. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Bristol-Myers Squibb Company is 55.31 (with a change from open of -1.02%), this in conjunction with a target price of 68.35. Volume today has so far reached 4072505, with an average volume of about 11000.19. The GAP for this stock, is 0.50%.

The P/E ratio is 32.53, bringing the forward P/E to a value of 18.55. The current EPS for Bristol-Myers Squibb Company, is 1.71, with a EPS growth for this year coming to a value of -22.30%. Performance has been interesting with performance year to date coming to -18.26%.

Looking further into the growth statistics for Bristol-Myers Squibb Company, EPS is looking like it will grow 14.04% in the next year. Looking even further it is projected to be 19.59%. Quarter over quarter is 990.60% for EPS growth and for sales growth quarter over quarter it is 17.00%. Looking at past EPS growth statistics we see that for the past five years it has been -12.20%. Sales growth for the past five years has in fact been -3.20%.

Looking at the ownership, we see that the insider ownership is at 0.10% and institutional ownership is 74.30%. Shares outstanding is 1681.98, while shares float is at a value of 1504.56. Float short for Bristol-Myers Squibb Company is 0.82% and the short ratio is 1.12.

In terms of debt, long term debt/equity is 0.44, while the total debt/equity comes to 0.45. The ability to meet these debts, means that the current ratio is 1.6, and the quick ratio is 1.4. The most recent gross margin is 75.70% and their operating margin is 20.80%. The profit margin is 16.30%.

Bristol-Myers Squibb Company has seen returns on assets of 9.00%, and on investment, 4.60%. Return on equity is 19.60%. Price/Earnings to growth ratio is 1.66. Price/Sales ratio is at a value of 5.31, with Price/book ratio coming to 6.23 and Price/cash is 20.11, and finally Price/Free cash Flow is .

The simple moving averages are -15.22% and -16.72% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -28.28% and the 52 week low is 0.53%.

Bristol-Myers Squibb Company has a dividend yield of 2.73%, with a current price of 55.31. The ability to pay this means the payout ratio is 87.80%. This is in an industry, Drug Manufacturers – Major, with equally high dividends from other companies in this sector, which it is Healthcare. Bristol-Myers Squibb Company is based in USA.

Performance in the Drug Manufacturers – Major industry means that Bristol-Myers Squibb Company has seen performance for the past week of -0.11%, with performance for the month coming to -4.63%. Looking at the data for the quarter it is at a value of -20.91%, and for the half year the performance is -8.52%. Volatility for this week is 1.95% and for the month this is 1.91%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment